[PERSON]
Sebastián Dalla Torre
Featured in 1 tracked story · first seen
Situations
Expanding therapeutic uses and regulatory approvals for GLP-
33 clusters · 154 sources · last updated
Latest: GLP-1 medications show weight loss challenges regarding muscle mass and maintenance
Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow